Azitra, Inc. announces a private placement financing of approximately $10.5 million to support innovative protein and peptide research programs. Additional funding of up to $20.9 million is available upon cash exercise of warrants.
Amount Raised
$10.5 Million
Round Type
Post-IPO Equity
BranfordBiotechnologyTherapeuticsInvestors
Description
Azitra, Inc. has entered into a securities purchase agreement to raise approximately $31.4 million in total. The initial funding of about $10.5 million is aimed at advancing its cosmetic and cosmeceutical research programs. Participating investors include Stonepine Capital and Nantahala Capital, among others
Quick answer
Azitra raised $10.5 Million in a Post-IPO Equity round, dated March 19, 2026. Investors: Nantahala Capital and Stonepine Capital. Azitra is based in Branford, Connecticut, United States.
- How much did Azitra raise?
- Azitra raised $10.5 Million in a Post-IPO Equity round on March 19, 2026.
- Who invested in Azitra?
- Nantahala Capital and Stonepine Capital are named as investors in this round.
- What does Azitra do?
- Azitra is a clinical-stage biopharmaceutical company developing precision dermatology therapies using engineered strains of S. epidermidis.
- Where is Azitra based and how big is it?
- Azitra is based in Branford, Connecticut, United States. Fundz records about 12 employees.
- Who are the decision-makers at Azitra?
- Fundz holds 2 contacts at Azitra, including the Chief Financial Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Azitra that raised within 45 days of this round, from Fundz verified event records.
- mbiomics raised $35M (Series A) on April 29, 2026.
- Coultreon Biopharma raised $125M (Series A) on April 28, 2026.
- NewcelX raised $3.4M on April 27, 2026.
- Lighthouse Pharmaceuticals raised $15M (Series A) on April 22, 2026.
- Tortugas Neuroscience raised $106M (Series A) on April 21, 2026.
- Beeline Medicines raised $300M (Series A) on April 16, 2026.
Who to call at Azitra, and when
A new round usually means Azitra is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Azitra raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Azitra, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Azitra. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Azitra raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Azitra raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.